NIBSC - Update 26 30 September 2011

Enter a search term

Home Page > Spotlight > Influenza Resource Centre > Reagents > Update Archive

Update 26 30 September 2011

Update 26, 30 September 2011

Current availability from NIBSC of candidate influenza vaccine viruses, SRD reagents and neuraminidase reagents for use in the 2012 southern hemisphere and the 2011/2012 northern hemisphere season. (See below for pricing information)

Update 26, 30 September 2011

Southern Hemisphere 2011¹ and Northern Hemisphere 2011/2012^2,3

Candidate influenza vaccine viruses	NIBSC code
H1N1
A/California/7/2009 wild type virus	10/122
NYMC X-179A reassortant derived from A/California/7/2009	11/112
NYMC X-181 reassortant derived from A/California/7/2009	11/128
IVR-153 reassortant derived from A/California/7/2009	09/236
NIBRG-121 reassortant derived from A/California/7/2009	09/122
NIBRG-121xp reassortant derived from A/California/7/2009	09/268
NIBRG-122 reassortant derived from A/England/195/2009	09/130
NIB-74 reassortant derived from A/Christchurch/16/2010 (A/California/7/2009 – like)	10/216
NIB-74xp reassortant derived from A/Christchurch/16/2010(A/California/7/2009 – like)	11/186
H3N2
A/Perth/16/2009 wild type virus	11/106
NIB-64 reassortant derived from A/Perth/16/2009	09/280
NYMC X-185 reassortant derived from A/Guangdong-Luohu/1256/2009	09/274
NYMC X-187 reassortant derived from A/Victoria/210/2009	11/108
NIB-65 reassortant derived from A/Victoria/210/2009	09/298
IVR-155 reassortant derived from A/Victoria/210/2009	09/304
B
B/Brisbane/60/2008	10/244
B/Brisbane/33/2008	08/280
NYMC BX-31 reassortant derived from B/Brisbane/60/2008	10/276
NIB-58 reassortant derived from B/Brisbane/60/2008	10/260
NYMC BX-35 reassortant derived from B/Brisbane/60/2008	09/318
NYMC BX-39 reassortant derived from B/Hubei Wjiagang/158/2009	10/270

³ http://www.ema.europa.eu/docs/en_GB/document_library/Other/2011/03/WC500103708.pdf

Reagents for influenza vaccine standardisation	NIBSC code
H1N1
A/California/7/2009 (NYMC X-179A) egg derived antigen	09/146
A/California/7/2009 (NYMC X-179A) cell derived antigen	09/174
A/California/7/2009 (NIBRG-121xp) egg derived antigen	09/196
A/California/7/2009 (NYMC X-181)	09/294
A/Christchurch/16/2010 (NIB-74)	10/258
A/Brisbane/10/2010 cell derived antigen	11/134
A/California/7/2009 antiserum	11/110
H3N2
A/Perth/16/2009 like antigen A/Wisconsin/15/2009 (NYMC X-183)	09/310
A/Perth/16/2009 like antigen A/Victoria/210/2009 (NYMC X-187)	10/102
A/Perth/16/2009 like antiserum	10/182
B
B/Brisbane/60/2008 antigen	08/352
B/Brisbane/60/2008 like antigen (NYMC BX-35)	10/106
B/Brisbane/60/2008 like antiserum	11/136

Neuraminidase reagents	NIBSC code
N1
Antiserum prepared from A/California/7/2009	10/218
antiserum prepared from A/New Caledonia/20/99	04/230
N2
antiserum prepared from A/Wyoming/3/2003	04/258
B
NA antiserum prepared from B/Jiangsu/10/2003	04/228
NA antiserum prepared from B/Malaysia/2506/2004	05/252
NA antiserum prepared for B/Florida/4/2006	09/316

Pricing information

Viruses are free of charge (normally a maximum of two vials per recipient), but customers are expected to pay shipping and packing costs. Reagents for Single Radial Diffusion assay are subject to the usual NIBSC handling charge of £66 per vial, plus shipping and packing costs. Approved National Control Laboratories for human health are exempt from the £66 handling fee.